Northern Trust
RLAY icon

Northern Trust’s Relay Therapeutics RLAY Stock Holding History

Northern Trust’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5M Buy
1,953,456
+278,069
+17% +$4.04M ﹤0.01% 1411
2026
Q1 		$16.7M Buy
1,675,387
+536,699
+47% +$4.8M ﹤0.01% 1787
2025
Q4 		$9.63M Sell
1,138,688
-26,746
-2% -$191K ﹤0.01% 2105
2025
Q3 		$6.08M Buy
1,165,434
+3,342
+0.3% +$12.7K ﹤0.01% 2390
2025
Q2 		$4.02M Buy
1,162,092
+19,164
+2% +$57K ﹤0.01% 2581
2025
Q1 		$2.99M Sell
1,142,928
-27,051
-2% -$106K ﹤0.01% 2697
2024
Q4 		$4.82M Buy
1,169,979
+231,713
+25% +$1.26M ﹤0.01% 2525
2024
Q3 		$6.64M Buy
938,266
+123,854
+15% +$925K ﹤0.01% 2314
2024
Q2 		$5.31M Sell
814,412
-13,995
-2% -$95.6K ﹤0.01% 2361
2024
Q1 		$6.88M Buy
828,407
+4,057
+0.5% +$39.6K ﹤0.01% 2282
2023
Q4 		$9.08M Buy
824,350
+22,992
+3% +$194K ﹤0.01% 2138
2023
Q3 		$6.74M Buy
801,358
+7,130
+0.9% +$76.7K ﹤0.01% 2257
2023
Q2 		$9.98M Sell
794,228
-78,194
-9% -$973K ﹤0.01% 2065
2023
Q1 		$14.4M Sell
872,422
-9,873
-1% -$177K ﹤0.01% 1774
2022
Q4 		$13.2M Buy
882,295
+64,460
+8% +$1.23M ﹤0.01% 1821
2022
Q3 		$18.3M Buy
817,835
+18,886
+2% +$414K ﹤0.01% 1545
2022
Q2 		$13.4M Buy
798,949
+148,598
+23% +$3.18M ﹤0.01% 1806
2022
Q1 		$19.5M Sell
650,351
-34,039
-5% -$826K ﹤0.01% 1699
2021
Q4 		$21M Buy
684,390
+108,462
+19% +$3.43M ﹤0.01% 1733
2021
Q3 		$18.2M Buy
575,928
+53,822
+10% +$1.81M ﹤0.01% 1868
2021
Q2 		$19.1M Buy
522,106
+77,973
+18% +$2.57M ﹤0.01% 1917
2021
Q1 		$15.4M Buy
444,133
+88,240
+25% +$3.83M ﹤0.01% 2011
2020
Q4 		$14.8M Sell
355,893
-2,165
-0.6% -$97.9K ﹤0.01% 2004
2020
Q3 		$15.2M Buy
+358,058
New +$13.7M ﹤0.01% 1825

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Northern Trust's RLAY Position: Q2 2026 in Review

Northern Trust increased its Relay Therapeutics (RLAY) stake by 17% in Q2 2026, buying an estimated $4.04M and bringing the position to 1,953,456 shares worth $36.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Northern Trust first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Northern Trust held 1,953,456 shares of Relay Therapeutics worth $36.5M as of Q2 2026.
  • Northern Trust bought 278,069 Relay Therapeutics shares in Q2 2026, an estimated $4.04M.
  • Relay Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1411 holding.
  • Northern Trust first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.